3a).

These same explant culture supernatants were also analysed by immunoblot using the anti-IL-2 monoclonal antibody JES6-1A12 and by functional https://www.selleckchem.com/products/midostaurin-pkc412.html analysis using the IL-2-dependent cell line CTLL-2. In Fig. 3(b), a lower apparent molecular weight band of approximately 20 000 MW reactive with anti-IL-2 (cleaved) increased with time of culture in the TG explant cultures, but not in the NTG cultures. These data suggest that other proteases that might be expressed by prostate cells did not cleave the IL-2/PSAcs/IL-2Rα fusion protein effectively but that human PSA derived from the prostate cells in the TG mouse could cleave the fusion protein. These same supernatants were also analysed for functional IL-2 activity (Fig. 3c). The amount of biologically active IL-2 was approximately eightfold higher in the TG explant cultures compared with the NTG cultures. This experiment has been repeated three times with the degree of enhancement of IL-2 activity ranging from fivefold to tenfold. As an additional, and perhaps more stringent, test of specific Lapatinib chemical structure cleavage of the fusion

protein by PSA but not by other proteases found in the prostate, we made extracts of prostates from PSA TG and NTG mice, and examined the ability of these extracts to cleave the fusion protein in the absence of any protease inhibitors that might be found in fetal calf serum. As shown in Fig. 3(d), the TG prostate extracts contain large amounts of PSA in comparison to the NTG extracts. As can be seen in the immunoblot analysis in Docetaxel purchase Fig. 3(e), the extracts from the PSA TG mice effectively cleaved the fusion protein, whereas the NTG extracts did not. Importantly, there was an increase in the functional

activity of the IL-2 assessed by the CTLL-2 assay after incubation with the PSA-containing TG extracts compared with the NTG extracts (Fig. 3f). The previous approach used a receptor as the inhibitory component in the fusion protein. We also investigated the ability of a single-chain Fv antibody fragment (scFv) to bind and inhibit IL-2. This strategy examines the importance of specific binding in the protease-activated cytokine approach by using a totally different binding component. The use of an scFv also has some potential theoretical advantages as we delineate in the discussion. The scFv constructs we developed are outlined schematically in Fig. 4(a). Here we were able to take advantage of an scFv phage display library previously constructed using human VH and VL gene segments.22,23 As this phage display library expressed human scFv, we used it to identify phages (phscFv) that bound human IL-2 (M. Sullivan, unpublished data) so that the components of the fusion protein constructed would all be derived from one species. From the small panel of phscFv that bound human IL-2 in a modified ELISA, we chose a phage (scFv-2) whose binding to IL-2 could be inhibited by a neutralizing anti-IL-2 antibody (Fig.